RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Development of safety profile evaluating pharmacokinetics, pharmacodynamics and toxicity of a combination of pioglitazone and olmesartan medoxomil in Wistar albino rats.

Development of safety profile evaluating pharmacokinetics, pharmacodynamics and toxicity of a combination of pioglitazone and olmesartan medoxomil in Wistar albino rats.

Add to Collection
2012 Feb Others Fist_Author_Year_PM

Full Author : ['Sengupta, Pinaki', 'Nandi, Utpal', 'Pal, Tapan Kumar']
Journal Title : Regulatory toxicology and pharmacology : RTP
Chapter : Section3
Journal Year : 2012
Cited by : Not Available

Pioglitazone (PIO), an antidiabetic drug and olmesartan medoxomil (OLM), an antihypertensive drug were administered orally alone and in combination to Wistar albino rats for evaluation of pharmacokinetics, pharmacodynamics and repeated dose 28-day oral to.....

Keywords : ["safety profile evaluate pharmacokinetic pharmacodynamic", "wistar albino rat", "olmesartan medoxomil", "toxicity", "pioglitazone", "development", "combination"]